You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
普瑞眼科(301239.SZ):創發企業已完成收購東莞光明眼科醫院35%股權
格隆匯 01-09 21:30

格隆匯1月9日丨普瑞眼科(301239.SZ)公佈,東莞光明眼科醫院於近日取得東莞市市場監督管理局核發的營業執照及《登記通知書》,創發企業收購東莞光明眼科醫院35%股權已完成工商變更登記手續。此次股權轉讓完成後,公司通過創發企業合計持有東莞光明眼科醫院80%股權,東莞光明眼科醫院將納入公司合併財務報表範圍。

東莞光明眼科醫院在東莞地區深耕眼科醫療20年,影響力遍及廣東省內,在區域內具備了較強的先發優勢和競爭優勢。此次交易順應眼科醫療發展的良好機遇,貫徹公司“全國連鎖化+同城一體化”發展戰略,為未來儘快完善廣東區域市場佈局,形成協同效應和規模效應,增強區域優勢,提升公司競爭優勢打下堅實的基礎。此次交易不會對公司財務狀況和經營狀況產生重大不利影響,不存在損害公司及股東利益的情形。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account